LABD - Direxion Daily S&P Biotech Bear 3X Shares

NYSEArca - NYSEArca Delayed Price. Currency in USD
21.57
-1.27 (-5.56%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close22.84
Open0.00
Bid21.51 x 900
Ask0.00 x 900
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,323,133
Net Assets93.55M
NAV22.83
PE Ratio (TTM)N/A
Yield1.32%
YTD Daily Total Return-45.90%
Beta (3Y Monthly)-4.62
Expense Ratio (net)1.11%
Inception Date2015-05-28
Trade prices are not sourced from all markets
  • 6 Best Leveraged Inverse ETFs of Past Week
    Zacks

    6 Best Leveraged Inverse ETFs of Past Week

    We have highlighted six leveraged inverse ETFs that are up more than 15% over the past week.

  • Day Trading With Leveraged ETFs
    Investopedia

    Day Trading With Leveraged ETFs

    Day trading using leveraged exchange traded funds (ETFs) is a high-risk undertaking but can return profit due to the volatile nature of the trade structure.

  • 5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2
    Zacks

    5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2

    Volatility and uncertainty has resulted in a strong demand for leveraged and inverse-leveraged ETFs as these could fetch outsized returns on quick market turns in a short span.

  • TheStreet.com

    In the Age of Algorithms

    The indices are well off the early lows Tuesday afternoon, but the question is whether they will manage another strong finish. The automatic buying of any dips smacks of compliancy, but in the age of algorithms, patterns tend to repeat much longer than they have in the past. In the 'old' days, the conventional wisdom was that when a pattern becomes common knowledge, it tended to stop working as traders anticipated it and undermined the movement.

  • Benzinga

    Big Moves In Leveraged Biotech ETFs

    Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action. What Happened Entering Monday, the Direxion Daily S&P Biotech ...

  • Benzinga

    This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders

    Biotechnology stocks and the related exchange traded funds are off to sizzling starts in 2019. The soaring start to 2019 by the equal-weight S&P Biotechnology Select Industry Index is lifting the fortunes of the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU). LABU, one of the largest leveraged biotechnology ETFs, is up more than 45 percent year-to-date, easily making it ne of Direxion's best-performing leveraged bullish ETFs in the month of January.

  • 7 Inverse ETFs That Soared More Than 70% in Q4
    Zacks

    7 Inverse ETFs That Soared More Than 70% in Q4

    The myriad woes have resulted in huge demand for inverse or leveraged inverse ETFs for investors seeking to make big gains in a short span.

  • Benzinga

    The Time Could Be Right For This Biotech ETF

    Biotechnology stocks and exchange traded funds have been slumping since last week's midterm elections and that could be an ominous sign. Ongoing weakness for the equal-weight S&P Biotechnology Select Industry Index benefits the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD). LABD, one of the most heavily traded leveraged biotechnology ETFs, aims to deliver triple the daily inverse returns of the S&P Biotechnology Select Industry Index.